Globus Medical Stock Price, News & Analysis (NYSE:GMED)

$38.53 -0.46 (-1.18 %)
(As of 12/14/2017 04:00 PM ET)
Previous Close$38.99
Today's Range$38.44 - $39.37
52-Week Range$23.44 - $41.70
Volume359,085 shs
Average Volume685,705 shs
Market Capitalization$3.70 billion
P/E Ratio30.74
Dividend YieldN/A
Beta0.58

About Globus Medical (NYSE:GMED)

Globus Medical logoGlobus Medical, Inc. (Globus) is a medical device company focused on the design, development and commercialization of musculoskeletal implants that promote healing in patients with spine disorders. The Company is focused on implants that promote healing in patients with spine disorders. The Company's products fall into one of two categories: Innovative Fusion or Disruptive Technologies. The Company sells its products through exclusive sales force in the United States, as well as within North, Central & South America, Europe, Asia, Africa and Australia. The sales force consists of direct sales representatives and distributor sales representatives employed by exclusive independent distributors.

Receive GMED News and Ratings via Email

Sign-up to receive the latest news and ratings for GMED and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Equipment, Supplies & Distribution
Sub-IndustryHealth Care Equipment
SectorMedical
SymbolNYSE:GMED
CUSIP37957720
Phone610-930-1800

Debt

Debt-to-Equity RatioN/A
Current Ratio7.52%
Quick Ratio6.03%

Price-To-Earnings

Trailing P/E Ratio30.74
Forward P/E Ratio30.34
P/E Growth2.92

Sales & Book Value

Annual Sales$563.99 million
Price / Sales6.58
Cash Flow$1.68 per share
Price / Cash22.92
Book Value$8.67 per share
Price / Book4.44

Profitability

Trailing EPS$1.10
Net Income$104.34 million
Net Margins17.54%
Return on Equity13.67%
Return on Assets12.35%

Miscellaneous

Employees1,400
Outstanding Shares96,380,000

Globus Medical (NYSE:GMED) Frequently Asked Questions

What is Globus Medical's stock symbol?

Globus Medical trades on the New York Stock Exchange (NYSE) under the ticker symbol "GMED."

How were Globus Medical's earnings last quarter?

Globus Medical Inc (NYSE:GMED) issued its quarterly earnings results on Wednesday, November, 8th. The medical device company reported $0.30 earnings per share (EPS) for the quarter, hitting the Zacks' consensus estimate of $0.30. The medical device company had revenue of $151.74 million for the quarter, compared to analyst estimates of $150.73 million. Globus Medical had a return on equity of 13.67% and a net margin of 17.54%. The business's revenue was up 11.9% on a year-over-year basis. During the same period in the previous year, the company posted $0.29 earnings per share. View Globus Medical's Earnings History.

When will Globus Medical make its next earnings announcement?

Globus Medical is scheduled to release their next quarterly earnings announcement on Monday, February, 26th 2018. View Earnings Estimates for Globus Medical.

What guidance has Globus Medical issued on next quarter's earnings?

Globus Medical issued an update on its FY17 earnings guidance on Wednesday, November, 8th. The company provided earnings per share (EPS) guidance of approx $1.27 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.26. The company issued revenue guidance of approx $625 million, compared to the consensus revenue estimate of $624.76 million.

Where is Globus Medical's stock going? Where will Globus Medical's stock price be in 2017?

12 Wall Street analysts have issued 1 year target prices for Globus Medical's shares. Their predictions range from $29.00 to $46.00. On average, they expect Globus Medical's stock price to reach $36.83 in the next twelve months. View Analyst Ratings for Globus Medical.

What are Wall Street analysts saying about Globus Medical stock?

Here are some recent quotes from research analysts about Globus Medical stock:

  • 1. According to Zacks Investment Research, "Globus Medical, Inc. is a medical device company focused on the design, development and commercialization of products that promote healing in patients with spine disorders. The Company's products fall into one of two categories: innovative fusion or disruptive technologies. Its innovative fusion products address a broad range of spinal fusion surgical procedures. Its disruptive technology products include minimally invasive surgical, motion preservation and advanced biomaterials technologies. Globus Medical, Inc. is based in Audubon, Pennsylvania. " (11/10/2017)
  • 2. Needham & Company LLC analysts commented, "GMED’s core spine organic growth has slowed though we expect some improvement in 2018 due to sales force enhancements. Its Emerging Technologies business should begin to add to growth in 2018 as well. But even accounting for this, we’re concerned that consensus 2018 estimates may be too high. And we believe that GMED’s earnings growth is going to be mostly driven by revenue growth." (9/26/2017)
  • 3. Barclays PLC analysts commented, "ELGX’s 2Q17 sales of $48.6M (-4.7%) came in ahead of our/consensus estimates of $47.6M; higher OUS sales offset lighter US results impacted by sales force attrition and lower AFX2 sales recapture. Ovation growth remained strong. Net loss was better on higher sales, better GM, and lower opex. ELGX lowered FY17 guidance by $9M at the midpoint to $185-190M on lower AFX2 sales recapture and sales force attrition. ELGX expects to begin PMA enrollment for Gen2 Nellix in late 2017/early 2018. We expect a slight uptick in 2H17 sales as AFX2 US softness continues, offset by Ovation US growth. We assume higher growth in ’18 versus ’17 on easier ’17 comps from both AFX manufacturing issues and the narrowed Nellix IFU." (8/3/2017)

Who are some of Globus Medical's key competitors?

Who are Globus Medical's key executives?

Globus Medical's management team includes the folowing people:

  • David C. Paul, Executive Chairman of the Board (Age 50)
  • Anthony L. Williams, President (Age 46)
  • David M. Demski, Chief Executive Officer, Director (Age 59)
  • Daniel T. Scavilla, Chief Financial Officer, Senior Vice President (Age 52)
  • Andrew Brett Murphy, Group President, Commercial Operations (Age 52)
  • Kurt C. Wheeler, Lead Independent Director (Age 64)
  • David D. Davidar, Director (Age 51)
  • Daniel T. Lemaitre, Independent Director (Age 63)
  • Robert W. Liptak CPA, Independent Director (Age 53)
  • Ann D. Rhoads, Independent Director (Age 51)

Who owns Globus Medical stock?

Globus Medical's stock is owned by many different of retail and institutional investors. Top institutional investors include Janus Henderson Group PLC (3.30%), Bank of New York Mellon Corp (2.47%), Dimensional Fund Advisors LP (1.91%), Van Berkom & Associates Inc. (1.91%), Oak Ridge Investments LLC (1.36%) and NWQ Investment Management Company LLC (0.90%). Company insiders that own Globus Medical stock include A Brett Murphy, Anthony L Williams, David D Davidar, Kurt Wheeler and Robert Liptak. View Institutional Ownership Trends for Globus Medical.

Who sold Globus Medical stock? Who is selling Globus Medical stock?

Globus Medical's stock was sold by a variety of institutional investors in the last quarter, including Oak Ridge Investments LLC, Rice Hall James & Associates LLC, Bank of New York Mellon Corp, Van Berkom & Associates Inc., Schroder Investment Management Group, OxFORD Asset Management LLP, Russell Investments Group Ltd. and Paradigm Capital Management Inc. NY. Company insiders that have sold Globus Medical company stock in the last year include A Brett Murphy, Anthony L Williams and David D Davidar. View Insider Buying and Selling for Globus Medical.

Who bought Globus Medical stock? Who is buying Globus Medical stock?

Globus Medical's stock was bought by a variety of institutional investors in the last quarter, including NWQ Investment Management Company LLC, American Century Companies Inc., Nuance Investments LLC, Janus Henderson Group PLC, Point72 Asset Management L.P., APG Asset Management N.V., Columbia Partners L L C Investment Management and Wells Fargo & Company MN. View Insider Buying and Selling for Globus Medical.

How do I buy Globus Medical stock?

Shares of Globus Medical can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Globus Medical's stock price today?

One share of Globus Medical stock can currently be purchased for approximately $38.53.

How big of a company is Globus Medical?

Globus Medical has a market capitalization of $3.70 billion and generates $563.99 million in revenue each year. The medical device company earns $104.34 million in net income (profit) each year or $1.10 on an earnings per share basis. Globus Medical employs 1,400 workers across the globe.

How can I contact Globus Medical?

Globus Medical's mailing address is 2560 GENERAL ARMISTEAD AVENUE, AUDUBON PA, 19403. The medical device company can be reached via phone at 610-930-1800 or via email at [email protected]


MarketBeat Community Rating for Globus Medical (GMED)

Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  309 (Vote Outperform)
Underperform Votes:  233 (Vote Underperform)
Total Votes:  542
MarketBeat's community ratings are surveys of what our community members think about Globus Medical and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Globus Medical (NYSE:GMED) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score: 2.402.252.332.14
Ratings Breakdown: 1 Sell Rating(s)
7 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
2 Sell Rating(s)
8 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
2 Sell Rating(s)
6 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
3 Sell Rating(s)
6 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $32.10$28.55$28.36$27.45
Price Target Upside: 14.67% downside23.49% downside5.52% downside9.48% downside

Globus Medical (NYSE:GMED) Consensus Price Target History

Price Target History for Globus Medical (NYSE:GMED)

Globus Medical (NYSE:GMED) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
12/4/2017Wells Fargo & CompanyUpgradeMarket Perform -> Outperform$46.00HighView Rating Details
11/20/2017BTIG ResearchSet Price TargetBuy$42.00N/AView Rating Details
11/14/2017GabelliReiterated RatingBuyN/AView Rating Details
11/10/2017Bank of AmericaUpgradeUnderperform -> NeutralN/AView Rating Details
11/9/2017Canaccord GenuityReiterated RatingBuy$38.00N/AView Rating Details
11/9/2017BarclaysBoost Price TargetUnderweight$27.00 -> $29.00N/AView Rating Details
11/9/2017Needham & Company LLCReiterated RatingHoldN/AView Rating Details
10/19/2017Piper Jaffray CompaniesReiterated RatingBuyN/AView Rating Details
8/30/2017OppenheimerReiterated RatingHoldHighView Rating Details
7/11/2017Morgan StanleyReiterated RatingEqual WeightLowView Rating Details
4/12/2017Leerink SwannUpgradeMarket Perform -> OutperformHighView Rating Details
2/28/2017AegisReiterated RatingBuy$31.00N/AView Rating Details
11/9/2016William BlairDowngradeOutperform -> Market PerformN/AView Rating Details
11/9/2016CitigroupDowngradeMarket Perform$29.00 -> $23.00N/AView Rating Details
11/9/2016JMP SecuritiesDowngradeOutperform -> Market PerformN/AView Rating Details
5/26/2016Goldman Sachs GroupDowngradeNeutral -> Sell$21.00N/AView Rating Details
5/4/2016Brean CapitalReiterated RatingBuyN/AView Rating Details
(Data available from 12/14/2015 forward)

Earnings

Globus Medical (NYSE:GMED) Earnings History and Estimates Chart

Earnings by Quarter for Globus Medical (NYSE:GMED)

Globus Medical (NYSE GMED) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/26/2018$0.34N/AView Earnings Details
11/8/2017Q3 2017$0.30$0.30$150.73 million$151.74 millionViewN/AView Earnings Details
8/2/2017Q2 2017$0.30$0.32$150.94 million$152.39 millionViewListenView Earnings Details
5/3/2017Q1 2017$0.31$0.32$155.81 millionViewListenView Earnings Details
2/27/2017Q416$0.33$0.31$149.30 million$151.59 millionViewListenView Earnings Details
11/8/2016Q3$0.28$0.29$139.25 million$135.70 millionViewListenView Earnings Details
7/26/2016Q2$0.29$0.29$141.78 million$137.49 millionViewListenView Earnings Details
5/3/2016Q1$0.28$0.29$140.30 million$139.30 millionViewListenView Earnings Details
2/24/2016Q4$0.30$0.32$141.20 million$142.60 millionViewListenView Earnings Details
11/3/2015Q3$0.25$0.28$127.46 million$137.00 millionViewListenView Earnings Details
7/30/2015Q215$0.25$0.25$126.89 million$133.60 millionViewListenView Earnings Details
5/5/2015Q115$0.24$0.26$122.30 million$131.60 millionViewListenView Earnings Details
2/25/2015Q414$0.25$0.30$127.77 million$128.80 millionViewListenView Earnings Details
10/30/2014Q314$0.21$0.24$113.10 million$117.80 millionViewListenView Earnings Details
8/5/2014Q214$0.23$0.23$119.83 million$113.60 millionViewListenView Earnings Details
4/29/2014Q114$0.22$0.24$113.59 million$114.20 millionViewListenView Earnings Details
2/26/2014Q413$0.22$0.25$114.96 million$115.20 millionViewListenView Earnings Details
10/30/2013Q313$0.19$0.22$106.00 million$107.19 millionViewListenView Earnings Details
8/1/2013Q2 2013$0.20$0.21$107.46 million$107.00 millionViewListenView Earnings Details
5/2/2013Q1 2013$0.20$0.21$103.14 million$105.00 millionViewListenView Earnings Details
2/27/2013Q4 2012$0.19$0.22$99.13 million$100.50 millionViewListenView Earnings Details
11/1/2012Q312$0.19$0.18$95.32 million$94.76 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Globus Medical (NYSE:GMED) Earnings Estimates

Current Year EPS Consensus Estimate: $1.27 EPS
Next Year EPS Consensus Estimate: $1.37 EPS

Dividends

Dividend History for Globus Medical (NYSE:GMED)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Globus Medical (NYSE GMED) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 28.21%
Institutional Ownership Percentage: 72.20%
Insider Trades by Quarter for Globus Medical (NYSE:GMED)
Institutional Ownership by Quarter for Globus Medical (NYSE:GMED)

Globus Medical (NYSE GMED) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/13/2017Anthony L WilliamsPresidentSell15,000$38.30$574,500.00View SEC Filing  
12/4/2017David D DavidarDirectorSell55,383$40.66$2,251,872.78View SEC Filing  
11/9/2017A Brett MurphyInsiderSell51,449$35.00$1,800,715.00View SEC Filing  
9/6/2017A Brett MurphyInsiderSell15,000$29.99$449,850.00View SEC Filing  
6/5/2017Anthony L WilliamsPresidentSell16,153$31.94$515,926.82View SEC Filing  
8/5/2016A Brett MurphyInsiderSell107,692$23.37$2,516,762.04View SEC Filing  
1/6/2016Robert LiptakDirectorSell15,300$27.50$420,750.00View SEC Filing  
1/4/2016Kurt WheelerDirectorSell255$27.50$7,012.50View SEC Filing  
5/28/2015Steven PayneCAOSell3,076$25.92$79,729.92View SEC Filing  
3/19/2015David C PaulCEOSell1,922,000$25.00$48,050,000.00View SEC Filing  
1/15/2014David DemskiCOOSell96,813$20.51$1,985,634.63View SEC Filing  
12/31/2013David DemskiCOOSell3,187$20.25$64,536.75View SEC Filing  
12/20/2013David DemskiCOOSell50,000$19.75$987,500.00View SEC Filing  
12/6/2013Robert LiptakDirectorSell25,000$19.36$484,000.00View SEC Filing  
12/3/2013David DavidarVPSell75,000$19.25$1,443,750.00View SEC Filing  
11/27/2013David DemskiCOOSell37,323$19.25$718,467.75View SEC Filing  
11/1/2013David M DemskiCOOSell112,677$18.59$2,094,665.43View SEC Filing  
8/23/2013David DavidarVPSell7,278$18.20$132,459.60View SEC Filing  
8/22/2013David DemskiCOOSell44,154$17.95$792,564.30View SEC Filing  
7/5/2013David D DavidarVPSell10,000$17.15$171,500.00View SEC Filing  
7/1/2013David D DavidarVPSell20,000$16.56$331,200.00View SEC Filing  
6/26/2013David D DavidarVPSell150,000$16.71$2,506,500.00View SEC Filing  
8/8/2012David C PaulCEOSell3,039,385$11.16$33,919,536.60View SEC Filing  
8/8/2012David D DavidarVPSell166,885$11.16$1,862,436.60View SEC Filing  
8/8/2012David M DemskiCOOSell98,957$11.16$1,104,360.12View SEC Filing  
8/8/2012Kurt WheelerDirectorSell804,232$11.16$8,975,229.12View SEC Filing  
8/8/2012Steven PayneCAOSell2,305$11.16$25,723.80View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Globus Medical (NYSE GMED) News Headlines

Source:
DateHeadline
Globus Medical Inc (GMED) President Sells $574,500.00 in StockGlobus Medical Inc (GMED) President Sells $574,500.00 in Stock
www.americanbankingnews.com - December 14 at 5:34 PM
Globus Medical Inc (GMED) Expected to Announce Earnings of $0.34 Per ShareGlobus Medical Inc (GMED) Expected to Announce Earnings of $0.34 Per Share
www.americanbankingnews.com - December 14 at 9:50 AM
Globus Medical Inc Forecasted to Earn FY2020 Earnings of $1.65 Per Share (GMED)Globus Medical Inc Forecasted to Earn FY2020 Earnings of $1.65 Per Share (GMED)
www.americanbankingnews.com - December 14 at 12:50 AM
Globus Medical Inc (GMED) Forecasted to Post FY2019 Earnings of $1.50 Per ShareGlobus Medical Inc (GMED) Forecasted to Post FY2019 Earnings of $1.50 Per Share
www.americanbankingnews.com - December 13 at 11:28 PM
Head-To-Head Contrast: Baxter International (BAX) vs. Globus Medical (GMED)Head-To-Head Contrast: Baxter International (BAX) vs. Globus Medical (GMED)
www.americanbankingnews.com - December 10 at 5:22 AM
Head-To-Head Contrast: Globus Medical (GMED) and Its PeersHead-To-Head Contrast: Globus Medical (GMED) and Its Peers
www.americanbankingnews.com - December 9 at 5:30 AM
Analyzing Globus Medical (GMED) & Its RivalsAnalyzing Globus Medical (GMED) & Its Rivals
www.americanbankingnews.com - December 7 at 11:34 PM
Globus Medical (GMED) and Its Peers Critical ReviewGlobus Medical (GMED) and Its Peers Critical Review
www.americanbankingnews.com - December 7 at 3:38 PM
Insider Selling: Globus Medical, Inc. (GMED) Director Sells 55,383 Shares of StockInsider Selling: Globus Medical, Inc. (GMED) Director Sells 55,383 Shares of Stock
www.americanbankingnews.com - December 6 at 5:22 PM
Globus Medical (GMED) and Its Rivals Head to Head AnalysisGlobus Medical (GMED) and Its Rivals Head to Head Analysis
www.americanbankingnews.com - December 5 at 3:30 PM
Bloomberg Markets: CVS Buying Aetna, Facebook’s New Kids AppBloomberg Markets: CVS Buying Aetna, Facebook’s New Kids App
www.bloomberg.com - December 5 at 10:02 AM
Wells Fargo & Company Upgrades Globus Medical (GMED) to "Outperform"Wells Fargo & Company Upgrades Globus Medical (GMED) to "Outperform"
www.americanbankingnews.com - December 4 at 8:58 PM
Globus Medical (GMED) Downgraded by ValuEngineGlobus Medical (GMED) Downgraded by ValuEngine
www.americanbankingnews.com - December 3 at 12:06 PM
Globus Medical Announces Clinical Results Showing Superiority of its SECURE-C® to ACDF at Seven Years - GlobeNewswire (press release)Globus Medical Announces Clinical Results Showing Superiority of its SECURE-C® to ACDF at Seven Years - GlobeNewswire (press release)
globenewswire.com - December 1 at 4:44 PM
Report: Developing Opportunities within Procter & Gamble, ACADIA Pharmaceuticals, Cree, Umpqua, Westrock, and Globus Medical — Future Expectations, Projections Moving into 2018Report: Developing Opportunities within Procter & Gamble, ACADIA Pharmaceuticals, Cree, Umpqua, Westrock, and Globus Medical — Future Expectations, Projections Moving into 2018
finance.yahoo.com - November 30 at 9:32 AM
Globus Medical, Inc. (GMED) Given Consensus Rating of "Buy" by AnalystsGlobus Medical, Inc. (GMED) Given Consensus Rating of "Buy" by Analysts
www.americanbankingnews.com - November 30 at 3:38 AM
$165.40 Million in Sales Expected for Globus Medical, Inc. (GMED) This Quarter$165.40 Million in Sales Expected for Globus Medical, Inc. (GMED) This Quarter
www.americanbankingnews.com - November 28 at 9:50 AM
Technical Perspectives on Edwards Lifesciences, Globus Medical, Invacare, and Medtronic - PR Newswire (press release)Technical Perspectives on Edwards Lifesciences, Globus Medical, Invacare, and Medtronic - PR Newswire (press release)
www.prnewswire.com - November 28 at 9:14 AM
$0.34 EPS Expected for Globus Medical, Inc. (GMED) This Quarter$0.34 EPS Expected for Globus Medical, Inc. (GMED) This Quarter
www.americanbankingnews.com - November 26 at 9:12 AM
Globus Medical, Inc. (GMED) Upgraded to "Buy" by BidaskClubGlobus Medical, Inc. (GMED) Upgraded to "Buy" by BidaskClub
www.americanbankingnews.com - November 26 at 6:10 AM
Globus Medical (GMED) versus NuVasive (NUVA) Financial SurveyGlobus Medical (GMED) versus NuVasive (NUVA) Financial Survey
www.americanbankingnews.com - November 24 at 5:12 PM
Mazor Robotics Might Need to Worry About This Potential Rival the Most (Hint: It's Not Intuitive Surgical)Mazor Robotics Might Need to Worry About This Potential Rival the Most (Hint: It's Not Intuitive Surgical)
finance.yahoo.com - November 22 at 7:57 PM
Palomar Medical Technologies (PMTI) & Globus Medical (GMED) Head-To-Head ReviewPalomar Medical Technologies (PMTI) & Globus Medical (GMED) Head-To-Head Review
www.americanbankingnews.com - November 21 at 5:12 AM
Globus Medical, Inc. (GMED) Earns Buy Rating from BTIG ResearchGlobus Medical, Inc. (GMED) Earns Buy Rating from BTIG Research
www.americanbankingnews.com - November 20 at 8:58 AM
Globus Medical, Inc. (GMED) Receives "Buy" Rating from GabelliGlobus Medical, Inc. (GMED) Receives "Buy" Rating from Gabelli
www.americanbankingnews.com - November 14 at 4:00 PM
Stocks Showing Market Leadership: Globus Medical Earns 91 RS RatingStocks Showing Market Leadership: Globus Medical Earns 91 RS Rating
finance.yahoo.com - November 13 at 6:01 PM
Equities Analysts Set Expectations for Globus Medical, Inc.s FY2019 Earnings (GMED)Equities Analysts Set Expectations for Globus Medical, Inc.'s FY2019 Earnings (GMED)
www.americanbankingnews.com - November 13 at 5:34 PM
Globus Medical, Inc. (GMED) Insider A Brett Murphy Sells 51,449 SharesGlobus Medical, Inc. (GMED) Insider A Brett Murphy Sells 51,449 Shares
www.americanbankingnews.com - November 13 at 4:21 PM
Globus Medical (GMED) vs. Its Rivals Financial ContrastGlobus Medical (GMED) vs. Its Rivals Financial Contrast
www.americanbankingnews.com - November 12 at 11:54 PM
Globus Medical Reaches 80-Plus Relative Strength Rating BenchmarkGlobus Medical Reaches 80-Plus Relative Strength Rating Benchmark
finance.yahoo.com - November 12 at 9:55 AM
Globus Medical, Inc. (GMED) Upgraded to "Buy" at ValuEngineGlobus Medical, Inc. (GMED) Upgraded to "Buy" at ValuEngine
www.americanbankingnews.com - November 11 at 6:18 PM
Globus Medical, Inc. (GMED) Upgraded to Hold at Zacks Investment ResearchGlobus Medical, Inc. (GMED) Upgraded to Hold at Zacks Investment Research
www.americanbankingnews.com - November 11 at 2:56 PM
Globus Medical (GMED) Q3 Earnings In Line, View Reiterated - NasdaqGlobus Medical (GMED) Q3 Earnings In Line, View Reiterated - Nasdaq
www.nasdaq.com - November 11 at 6:59 AM
Globus Medical (GMED) Looks Good: Stock Adds 7.5% in Session - NasdaqGlobus Medical (GMED) Looks Good: Stock Adds 7.5% in Session - Nasdaq
www.nasdaq.com - November 11 at 6:59 AM
Globus Medical (GMED) Looks Good: Stock Adds 7.5% in SessionGlobus Medical (GMED) Looks Good: Stock Adds 7.5% in Session
finance.yahoo.com - November 11 at 6:59 AM
Globus Medical, Inc. (GMED) Raised to Neutral at Bank of America CorporationGlobus Medical, Inc. (GMED) Raised to Neutral at Bank of America Corporation
www.americanbankingnews.com - November 10 at 11:24 AM
Canaccord Genuity Reaffirms "Buy" Rating for Globus Medical, Inc. (GMED)Canaccord Genuity Reaffirms "Buy" Rating for Globus Medical, Inc. (GMED)
www.americanbankingnews.com - November 9 at 3:42 PM
Needham & Company LLC Reiterates "Hold" Rating for Globus Medical, Inc. (GMED)Needham & Company LLC Reiterates "Hold" Rating for Globus Medical, Inc. (GMED)
www.americanbankingnews.com - November 9 at 1:54 PM
Globus Medical (GMED) Q3 2017 Results - Earnings Call TranscriptGlobus Medical (GMED) Q3 2017 Results - Earnings Call Transcript
seekingalpha.com - November 9 at 6:09 AM
Globus Medical, Inc. Class A to Host Earnings CallGlobus Medical, Inc. Class A to Host Earnings Call
finance.yahoo.com - November 9 at 6:08 AM
Globus Medical Reports Third Quarter 2017 ResultsGlobus Medical Reports Third Quarter 2017 Results
finance.yahoo.com - November 9 at 6:08 AM
Globus Medical meets 3Q profit forecastsGlobus Medical meets 3Q profit forecasts
finance.yahoo.com - November 9 at 6:08 AM
Edited Transcript of GMED earnings conference call or presentation 8-Nov-17 10:30pm GMTEdited Transcript of GMED earnings conference call or presentation 8-Nov-17 10:30pm GMT
finance.yahoo.com - November 9 at 6:08 AM
Globus Medical, Inc. (GMED) Expected to Announce Quarterly Sales of $151.38 MillionGlobus Medical, Inc. (GMED) Expected to Announce Quarterly Sales of $151.38 Million
www.americanbankingnews.com - November 9 at 4:00 AM
Globus Medical, Inc. (GMED) Issues  Earnings ResultsGlobus Medical, Inc. (GMED) Issues Earnings Results
www.americanbankingnews.com - November 8 at 9:55 PM
Globus Medical, Inc. (GMED) Updates FY17 Earnings GuidanceGlobus Medical, Inc. (GMED) Updates FY17 Earnings Guidance
www.americanbankingnews.com - November 8 at 9:36 PM
Globus Medical Inc. Posts Solid 3rd-Quarter Results With Robots in Its FutureGlobus Medical Inc. Posts Solid 3rd-Quarter Results With Robots in Its Future
www.fool.com - November 8 at 8:49 PM
Globus Medical Inc (GMED): What Are The Future Prospects?Globus Medical Inc (GMED): What Are The Future Prospects?
finance.yahoo.com - November 8 at 8:04 AM
 Brokerages Expect Globus Medical, Inc. (GMED) Will Announce Earnings of $0.30 Per Share Brokerages Expect Globus Medical, Inc. (GMED) Will Announce Earnings of $0.30 Per Share
www.americanbankingnews.com - November 7 at 7:20 PM
Globus Medical, Inc. (GMED) Given Average Rating of "Hold" by BrokeragesGlobus Medical, Inc. (GMED) Given Average Rating of "Hold" by Brokerages
www.americanbankingnews.com - November 5 at 3:46 AM

SEC Filings

Globus Medical (NYSE:GMED) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Globus Medical (NYSE:GMED) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Globus Medical (NYSE GMED) Stock Chart for Thursday, December, 14, 2017

Loading chart…

This page was last updated on 12/14/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.